« Back to Record
Cortes, J., Vahdat, L. L., Blum, J., Twelves, C. J., Campone, M., Roche, H., Bachelot, T., Awada, A., Paridaens, R., Goncalves, A., Shuster, D., Wanders, J., Fang, F., Gurnani, R., Richmond, E., Cole, P. E., Ashworth, S., & Allison, M. (2010). Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine. Journal of clinical oncology, 28(25), 3922-3928. doi:10.1200/JCO.2009.25.8467
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/118198



